Viridian Therapeutics, Inc.\DEVRDN

Market cap

$2.6B

P/E ratio

	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	-	11	3	47	33	25	46	42	156	103	100
Marketable securities, current	-	-	-	-	30	2	82	309	269	375	618
Total cash & short-term investments	-	11	3	47	62	27	128	352	425	477	718
Accounts receivable, net	1	394,000	524,000	1	0	0	-	-	-	-	-
Inventories	0	187,000	0	-	-	-	-	-	-	-	-
Total current assets	7	12	4	52	65	30	130	200	431	486	738
Property, plant and equipment, net	1	1	-	1	1	1	0	0	1	2	1
Total non-current assets	1	1	-	1	1	1	2	4	4	4	4
Total assets	8	13	4	52	66	30	131	204	435	490	742
Accounts payable	0	242,000	0	1	1	1	1	2	14	2	2
Total current liabilities	2	2	5	4	7	10	11	14	33	27	48
Long-term debt, non-current	-	-	-	-	-	-	-	-	5	20	21
Total non-current liabilities	-	-	-	10	8	4	1	2	7	22	23
Total liabilities	-	-	-	14	15	15	11	16	40	48	71
Common stock and paid-in capital	13	28	5	132	178	184	218	412	741	961	1,479
Retained earnings	-7	-17,968,000	-31	-94	-126	-168	-279	-358	-488	-726	-996
Stockholders' equity	6	10	-0	39	51	16	120	188	395	442	672
Total debt	-	-	-	-	-	-	-	-	5	20	21
Net debt	-	-	-	-	-	-	-	-	-420	-457	-697
D/E ratio (%)	-	-	-	-	-	-	-	-	1.2	4.6	3.1
Working capital				-	-	-	-	-	-	-	-